3,6-bis(5-chloro-2-piperidyl)-2,5-piperazinedione has been researched along with Leukemia, Myeloid in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Benjamin, RS; Bodey, GP; Burgess, MA; Gottlieb, JA; Keating, MJ; Livingston, RA; McCredie, KB; Rodriguez, V; Valdivieso, M | 1 |
Dicke, KA; Hester, JP; Jagannath, S; Kantarjian, HM; McCredie, KB; Spitzer, G; Trujillo, J; Vellekoop, L; Zagars, G; Zander, AR | 1 |
1 trial(s) available for 3,6-bis(5-chloro-2-piperidyl)-2,5-piperazinedione and Leukemia, Myeloid
Article | Year |
---|---|
Phase I-II study of piperazinedione in adults with solid tumors and acute leukemia.
Topics: Adult; Antibiotics, Antineoplastic; Bone Marrow; Clinical Trials as Topic; Drug Evaluation; Female; Humans; Leukemia, Myeloid; Leukemia, Myeloid, Acute; Male; Melanoma; Neoplasms; Piperazines | 1979 |
1 other study(ies) available for 3,6-bis(5-chloro-2-piperidyl)-2,5-piperazinedione and Leukemia, Myeloid
Article | Year |
---|---|
Piperazinedione, total body irradiation, and autologous bone marrow transplantation in chronic myelogenous leukemia.
Topics: Adult; Antibiotics, Antineoplastic; Bone Marrow; Bone Marrow Transplantation; Female; Freezing; Granulocytes; Hematopoietic Stem Cells; Humans; Karyotyping; Leukemia, Myeloid; Leukocyte Count; Male; Middle Aged; Philadelphia Chromosome; Piperazines; Platelet Count; Preservation, Biological; Splenectomy; Whole-Body Irradiation | 1986 |